MLN4924 inhibits the NEDD8-activating enzyme, which then regulate T cell polarization in chronic lymphocytic leukemia (CLL) patients with lower Treg differentiation and a shift to the TH1 phenotype but increased production of IFN-γ (Best et al., 2021). Here, IFNG is linked to B-cell chronic lymphocytic leukemia.